CELL AND GENE THERAPY, INDUSTRIAL IMPACT

Single-cell RNA Sequencing and Analysis

March 1, 2023

Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets -  a 2 minute Preview of the Experimental Protocol.

Spotlight

Arvinas

Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

OTHER VIDEOS

VIA Thaw™ automated dry thawer

video | May 9, 2023

VIA Thaw™ dry automated thawers give you the confidence to reliably recover cryopreserved cellular products. VIA Thaw™ L1000 intended for research or manufacturing use only is an automated dry thawer that you can use for controlled, consistent thawing of cellular products in cryobags....

Watch Now

NeatCell C-Pro application software for the Sepax™ C-Pro instrument

video | May 9, 2023

Meet the NeatCell C-Pro application. It automates the mononuclear cell fraction enrichment from diverse cellular products, and is designed for use with a density-gradient medium like Ficoll-Paque media with the Sepax C-Pro instrument and CT-90.1 single-use kit....

Watch Now

Interview with the Chair of Bioprocess Engineering, TU Berlin

video | April 4, 2023

Professor Dr. Peter Neubauer leads research at the Chair of Bioprocess Engineering aiming to the development and application of new methods for faster bioprocess development, including genetic, cultivation, and analytical tools with a special focus on the industrial scale....

Watch Now

Thermo Scientific Lablink xL Quality Assurance Program software

video | March 30, 2023

Learn how a cloud-based QAP can help improve efficiency for QC data management, troubleshooting and peer groups comparison...

Watch Now

Spotlight

Arvinas

Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

Events